List of Tables
Table 1: Cancer Supportive Care Products Market, Global, Revenue ($m), 2001–2009 22
Table 2: Cancer Supportive Care Products Market, Global, Revenue Forecast ($m), 2009–2016 23
Table 3: Cancer Supportive Care Products Market, Global, Average Annual Cost of Therapy ($), 2001–2009 24
Table 4: Cancer Supportive Care Products Market, Global, Average Annual Cost of Therapy ($), 2009–2016 25
Table 5: Cancer Supportive Care Products Market, Geographical Segmentation, Revenue ($m), 2001–2009 28
Table 6: Cancer Supportive Care Products Market, Geographical Segmentation, Revenue ($m), 2009–2016 29
Table 7: Cancer Supportive Care Products Market, Sales of Generics Versus Branded Drugs ($m), 2001-2009 33
Table 8: Cancer Supportive Care Products Market, Sales of Generics Versus Branded Drugs ($m), 2009-2016 33
Table 9: Oral Mucositis and Dry Mouth, Global, Revenue ($m), 2001–2009 45
Table 10: Oral Mucositis and Dry Mouth, Global, Revenue Forecast ($m), 2009–2016 46
Table 11: Oral Mucositis and Dry Mouth, Global, Annual Cost of Therapy ($), 2001–2009 47
Table 12: Oral Mucositis and Dry Mouth, Global, Annual Cost of Therapy ($), 2009–2016 48
Table 13: Oral Mucositis and Dry Mouth, Global, Treatment Usage Pattern (‘000), 2001–2009 49
Table 14: Oral Mucositis and Dry Mouth, Global, Treatment Usage Pattern (‘000), 2009–2016 50
Table 15: Oral Mucositis and Dry Mouth, Geographical Segmentation, Revenue ($m), 2001–2009 54
Table 16: Oral Mucositis and Dry Mouth, Geographical Segmentation, Revenue ($m), 2009–2016 55
Table 17: Chemotherapy Induced Nausea and Vomiting, Emetic Risk Levels of Major Chemotherapeutic Agents 59
Table 18: Chemotherapy Induced Nausea and Vomiting, Global, Revenue ($m), 2001–2009 61
Table 19: Chemotherapy Induced Nausea and Vomiting, Global, Revenue Forecast ($m), 2009–2016 61
Table 20: Chemotherapy Induced Nausea and Vomiting, Global, Annual Cost of Therapy ($), 2001–2009 62
Table 21: Chemotherapy Induced Nausea and Vomiting, Global, Annual Cost of Therapy ($), 2009–2016 63
Table 22: Chemotherapy Induced Nausea and Vomiting, Global, Treatment Usage Pattern (‘000), 2001–2009 64
Table 23: Chemotherapy Induced Nausea and Vomiting, Global, Treatment Usage Pattern (‘000), 2009–2016 65
Table 24: Chemotherapy Induced Nausea and Vomiting, Geographical Segmentation, Revenue ($m), 2001–2009 70
Table 25: Chemotherapy Induced Nausea and Vomiting, Geographical Segmentation, Revenue ($m), 2009–2016 70
Table 26: Cancer Pain, Global, Revenue ($m), 2001–2009 74
Table 27: Cancer Pain, Global, Revenue Forecast ($m), 2009–2016 75
Table 28: Cancer Pain, Global, Annual Cost of Therapy ($), 2001-2009 76
Table 29: Cancer Pain, Global, Annual Cost of Therapy ($), 2009-2016 77
Table 30: Cancer Pain, Global, Treatment Usage Patterns (‘000), 2001-2009 78
Table 31: Cancer Pain, Global, Treatment Usage Patterns (‘000), 2009-2016 79
Table 32: Cancer Pain, Geographical Segmentation, Revenue ($m), 2001–2009 86
Table 33: Cancer Pain, Geographical Segmentation, Revenue ($m), 2009–2016 86
Table 34: Chemotherapy Induced Anemia, Global, Revenue ($m), 2001–2009 90
Table 35: Chemotherapy Induced Anemia, Global, Revenue Forecast ($m), 2009–2016 91
Table 36: Chemotherapy Induced Anemia, Global, Annual Cost of Therapy ($), 2001–2009 92
Table 37: Chemotherapy Induced Anemia, Global, Annual Cost of Therapy ($), 2009–2016 93
Table 38: Chemotherapy Induced Anemia, Global, Treatment Usage Pattern (‘000), 2001–2009 94
Table 39: Chemotherapy Induced Anemia, Global, Treatment Usage Pattern (‘000), 2009–2016 95
Table 40: Chemotherapy Induced Anemia, Geographical Segmentation, Revenue ($m), 2001–2009 100
Table 41: Chemotherapy Induced Anemia, Geographical Segmentation, Revenue ($m), 2009–2016 101
Table 42: Chemotherapy Induced Neutropenia, Global, Revenue ($m), 2001–2009 106
Table 43: Chemotherapy Induced Neutropenia, Global, Revenue Forecast ($m), 2009–2016 107
Table 44: Chemotherapy Induced Neutropenia, Global, Annual Cost of Therapy ($), 2001–2009 108
Table 45: Chemotherapy Induced Neutropenia, Global, Annual Cost of Therapy ($), 2009–2016 109
Table 46: Chemotherapy Induced Neutropenia, Global, Treatment Usage Pattern (‘000), 2001–2009 110
Table 47: Chemotherapy Induced Neutropenia, Global, Treatment Usage Pattern (‘000), 2009–2016 111
Table 48: Chemotherapy Induced Neutropenia, Geographical Segmentation, Revenue ($m), 2001–2009 116
Table 49: Chemotherapy Induced Neutropenia, Geographical Segmentation, Revenue ($m), 2009–2016 116
Table 50: Bone Metastases, Global, Revenue ($m), 2001–2009 120
Table 51: Bone Metastases, Global, Revenue Forecast ($m), 2009–2016 121
Table 52: Bone Metastases, Global, Annual Cost of Therapy ($), 2001–2009 122
Table 53: Bone Metastases, Global, Annual Cost of Therapy ($), 2009–2016 123
Table 54: Bone Metastases, Global, Treatment Usage Pattern (‘000), 2001–2009 124
Table 55: Bone Metastases, Global, Treatment Usage Pattern (‘000), 2009–2016 125
Table 56: Bone Metastases, Geographical Segmentation, Revenue ($m), 2001–2009 129
Table 57: Bone Metastases, Geographical Segmentation, Revenue ($m), 2009–2016 130
Table 58: Cancer Supportive Care Products Market, the US, Revenue ($m), 2001–2009 134
Table 59: Cancer Supportive Care Products Market, the US, Revenue Forecast ($m), 2009–2016 134
Table 60: Cancer Supportive Care Products Market, the US, Average Annual Cost of Therapy ($), 2001–2009 135
Table 61: Cancer Supportive Care Products Market, the US, Average Annual Cost of Therapy ($), 2009–2016 136
Table 62: Cancer Supportive Care Products Market, Top Five Countries of Europe, Revenue ($m), 2001–2009 139
Table 63: Cancer Supportive Care Products Market, Top Five Countries of Europe, Revenue Forecast ($m), 2009–2016 139
Table 64: Cancer Supportive Care Products Market, Top Five Countries of Europe, Average Annual Cost of Therapy ($), 2001–2009 140
Table 65: Cancer Supportive Care Products Market, Top Five Countries of Europe, Average Annual Cost of Therapy ($), 2009–2016 141
Table 66: Cancer Supportive Care Products Market, Japan, Revenue ($m), 2001–2009 145
Table 67: Cancer Supportive Care Products Market, Japan, Revenue Forecast ($m), 2009–2016 146
Table 68: Cancer Supportive Care Products Market, Japan, Average Annual Cost of Therapy ($), 2001–2009 147
Table 69: Cancer Supportive Care Products Market, Japan, Average Annual Cost of Therapy ($), 2009–2016 148
Table 70: Cancer Supportive Care Products Market, Global, Pipeline Products – Amgen, 2011 171
Table 71: Cancer Supportive Care Products Market, Global, Pipeline Products – Johnson & Johnson, 2011 174
Table 72: Cancer Supportive Care Products Market, Global, Pipeline Products – F. Hoffmann-La Roche, 2011 176
Table 73: Cancer Supportive Care Products Market, Global, Pipeline Products – Novartis, 2011 179
Table 74: Cancer Supportive Care Products Market, Global, Pipeline Products – Pfizer, 2011 182